If you’ve been researching treatments for melasma, dark spots, or post-inflammatory hyperpigmentation, you’ve probably come across familiar ingredients such as hydroquinone, kojic acid, tranexamic acid, azelaic acid, and niacinamide.
Many of these ingredients have substantial clinical experience behind them and remain important options in pigmentation care.
But skincare science never stands still.
Researchers continue to investigate ingredients that target pigmentation through different pathways. Three that have attracted growing attention are:
- Glutathione
- Cysteamine
- Isobutylamido Thiazolyl Resorcinol (ITR), commonly known by the trade name Thiamidol®
What’s interesting about these ingredients isn’t simply whether they can lighten pigmentation. Stability, odor, irritation, formulation design, and skin tolerability can all affect how practical they are in real life.
Let’s take a closer look.
1. Glutathione — More Than an Antioxidant
Glutathione is best known as one of the body’s important naturally occurring antioxidants, but researchers have also investigated its potential role in skin pigmentation.
Glutathione may influence melanogenesis in several ways, including interfering with tyrosinase activity and shifting melanin production toward lighter pheomelanin rather than darker eumelanin.
Clinical studies of topical glutathione have used different formulations and concentrations, and the evidence is still developing. A recent systematic review found that topical glutathione can have skin-lightening effects, but the quality of the available evidence varies and more research is needed.
The Formulation Challenge: Stability
Here’s something patients don’t often hear about: glutathione can be difficult to keep stable in a skincare formulation.
The active, reduced form of glutathione is known as GSH. When it oxidizes, it changes into another form called GSSG.
Think of it like a freshly cut apple slowly turning brown when exposed to air. The ingredient is still present, but its chemistry is gradually changing. Exposure to oxygen, heat, and humidity can accelerate this oxidation process. That is why careful formulation and packaging are particularly important for ingredients like glutathione. Minimizing exposure to air, heat, moisture, and other unfavorable conditions during preparation—and choosing appropriate packaging and storage conditions—can help protect the formulation and maintain its stability over time.
Glutathione also contains a sulfur-containing thiol group (-SH), which contributes to its characteristic odor. Some people describe the smell as sulfur-like, fishy, or similar to rotten eggs.
Glutathione: The Practical Takeaway
Glutathione is an interesting antioxidant with potential effects on pigmentation, but oxidation and odor can make it challenging to formulate. The clinical evidence for topical use is promising but remains less established than many traditional pigmentation treatments.
2. Cysteamine — Promising, but Not Always Easy to Use
Cysteamine may be unfamiliar to many skincare consumers, but it has been investigated for pigmentation for decades.
It is a naturally occurring molecule that appears to influence several pathways involved in melanin production, rather than acting through only one mechanism.
Clinical studies have most commonly investigated 5% topical cysteamine for melasma. A recent meta-analysis found that cysteamine improved melasma compared with placebo, while its overall efficacy was not statistically different from treatments such as hydroquinone-based regimens, modified Kligman’s formula, and tranexamic acid mesotherapy.
The Formulation Challenge: Odor, Oxidation and Irritation
Like glutathione, cysteamine contains a sulfur-containing thiol group (-SH). (Yes, it smells like glutathione!)
That small part of its chemical structure creates two practical challenges: cysteamine can oxidize relatively easily, and it has a distinctive sulfur-like odor.
In other words, some of the chemistry that makes cysteamine interesting also makes it challenging to turn into an elegant skincare product.
Another consideration is skin irritation.
Burning, itching, redness, dryness, and irritation have been reported in clinical studies. This doesn’t mean everyone will find cysteamine irritating, but tolerability is particularly important for people whose skin is prone to pigmentation.
Why?
Because inflammation itself can sometimes trigger post-inflammatory hyperpigmentation (PIH).
Some clinical studies have therefore used short-contact therapy, where cysteamine is applied for approximately 15–30 minutes and then washed off rather than remaining on the skin all day.
Cysteamine: The Practical Takeaway
Cysteamine has encouraging evidence for melasma, particularly at 5%, but odor, oxidation, and skin tolerability can influence whether it is practical for an individual patient.
3. Isobutylamido Thiazolyl Resorcinol — The Most Potent Inhibitor of Human Tyrosinase
Isobutylamido thiazolyl resorcinol (ITR), commonly known by the trade name Thiamidol®, works differently.
Its primary target is human tyrosinase—one of the key enzymes the skin uses to produce melanin.
Think of tyrosinase as part of the skin’s pigment-making machinery. By inhibiting this enzyme, ITR can interfere with one of the important steps involved in producing excess pigment.
One reason researchers became particularly interested in ITR is that it demonstrated very strong inhibition of human tyrosinase in laboratory screening.
Commonly Studied Concentration: 0.1–0.2%
Clinical research has commonly evaluated topical ITR at concentrations around 0.1–0.2%.
In one randomized controlled trial involving women with facial melasma, 0.2% ITR was compared with 4% hydroquinone for 90 days. Both groups experienced improvement, with no statistically significant difference between treatments for the main clinical outcomes.
A 2024 systematic review identified 14 clinical studies involving ITR and found improvement across conditions including melasma, post-inflammatory hyperpigmentation, facial hyperpigmentation, and UV-induced pigmentation. However, the authors also emphasized that the overall evidence remains limited and further research is needed.
Why ITR Is Interesting
Unlike glutathione and cysteamine, ITR does not have the same characteristic sulfur odor.
Published studies have also generally reported favorable short-term tolerability. However, ITR has a much shorter clinical history than established ingredients such as hydroquinone.
ITR: The Practical Takeaway
ITR is a newer human tyrosinase inhibitor that works at relatively low concentrations and has shown promising clinical results. However, its long-term and independent evidence base is still developing.
So, Which Ingredient Is Best?
There isn’t one ingredient that’s best for everyone.
And that’s perhaps the most important takeaway.
Someone with highly sensitive skin may need to prioritize tolerability. Someone with stubborn pigmentation may benefit from ingredients that target different pigmentation pathways. And someone who cannot tolerate an ingredient’s smell, texture, or irritation is unlikely to use it consistently enough to benefit from it.
For pigmentation-prone skin, stronger isn’t necessarily better.
The right treatment needs to balance clinical evidence, concentration, formulation stability, skin tolerance, and consistency of use.
Side Note: What About Tranexamic Acid Mesotherapy?
You may also come across tranexamic acid mesotherapy when researching treatments for melasma.
Unlike topical tranexamic acid, mesotherapy involves injecting small amounts of tranexamic acid into the skin. Clinical studies have reported improvement in melasma, and tranexamic acid mesotherapy has also been compared with topical cysteamine in published research.
However, mesotherapy is an in-office medical procedure, not simply another skincare ingredient. Injection discomfort, temporary redness, swelling, bruising, and the possibility of inflammation need to be considered, particularly in pigmentation-prone skin.
Research is promising, but treatment protocols vary and longer-term comparative evidence remains limited. Tranexamic acid mesotherapy should therefore be discussed with an appropriately qualified healthcare professional.
Why Personalization Matters — Especially for Skin of Color
Hyperpigmentation can be particularly challenging in Fitzpatrick skin types III–VI, where inflammation itself may stimulate additional pigment production.
That’s why treating pigmentation is often a balancing act between effectiveness and tolerability.
At Atria Compounding Pharmacy, personalized skincare begins by considering factors such as:
- Skin type and sensitivity
- Previous treatment response
- History of irritation
- Type and severity of pigmentation
- Current skincare routine
- Treatment goals
When appropriate, customization allows the ingredients, concentrations, and formulation base to be adjusted according to individual needs rather than simply choosing the strongest available concentration.
Because when treating hyperpigmentation, the goal isn’t simply to use more active ingredients.
It’s to find the right ingredients, at appropriate concentrations, in a formulation your skin can tolerate and use consistently.
References
- Klein PA, Kincaid C, Babadjouni A, Mesinkovska NA. Isobutylamido Thiazolyl Resorcinol (Thiamidol) for Combatting Hyperpigmentation: A Systematic Review of Clinical Studies. Journal of Drugs in Dermatology. 2024;23(11):986–991. https://pubmed.ncbi.nlm.nih.gov/39496126/
- Sarkar R, Yadav V, Yadav T, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. International Journal of Dermatology. 2025;64(6):992–1004. https://pubmed.ncbi.nlm.nih.gov/39444151/
- Wu BQ, Wang YJ, et al. Clinical Efficacy of Cysteamine Application for Melasma: A Meta-Analysis. Journal of Clinical Medicine. 2024;13(23):7483. https://pubmed.ncbi.nlm.nih.gov/39685940/
- Lima PB, Dias JAF, Cassiano DP, et al. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial. Journal of the European Academy of Dermatology and Venereology. 2021;35(9):1881–1887. https://pmc.ncbi.nlm.nih.gov/articles/PMC11022844/
- Ahmadi K, Miri A, Bizaval Z, et al. Assessing the Effectiveness of Stabilized Cysteamine 5% Cream Compared to Hydroquinone 4%/Ascorbic Acid 3% Combination Cream in Treating Acne-induced Post-inflammatory Hyperpigmentation: A Randomized, Controlled Study. Journal of Clinical and Aesthetic Dermatology. 2024;17(4):37–41. https://pmc.ncbi.nlm.nih.gov/articles/PMC11022844/
- Sarkar R, Sahu A, Mendiratta V. Efficacy and Safety of Cysteamine in Melasma in Patients of Skin of Colour: A Brief Report. Indian Dermatology Online Journal. 2025;16(2):276–279. https://pmc.ncbi.nlm.nih.gov/articles/PMC11927990/